Skip to main content

Table 1 Characteristics of the study population

From: Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients

n (%)

Total, n = 3739

Screeners, n = 1089 (29.1)

Non-screeners, n = 2260 (60.4)

Unaware, n = 390 (10.4)

P

Site, n (%)

     

 CGH

377 (10.1)

79 (7.3)

239 (10.6)

59 (15.1)

<0.001

 KKH

724 (19.4)

173 (15.9)

476 (21.1)

75 (19.2)

 

 NCC

704 (18.8)

260 (23.9)

391 (17.3)

53 (13.6)

 

 NTFGH

32 (0.9)

7 (0.6)

23 (1.0)

2 (0.5)

 

 NUH

630 (16.8)

164 (15.1)

398 (17.6)

68 (17.4)

 

 SGH

318 (8.5)

107 (9.8)

185 (8.2)

26 (6.7)

 

 TTSH

954 (25.5)

299 (27.5)

548 (24.2)

107 (27.4)

 

Sociodemographic factors

 Age at diagnosis (years, IQR)

 

60.0 (55.0–66.0)

58.0 (54.0–64.0)

60.0 (55.0–66.0)

66.0 (59.0–73.0)

<0.001

 Age at diagnosis (categorical), n (%)

  50–59

1800 (48.1)

610 (56.0)

1084 (48.0)

106 (27.2)

<0.001

  ≥60

1939 (51.9)

479 (44.0)

1176 (52.0)

284 (72.8)

 

 Ethnicity, n (%)

     

  Chinese

3000 (80.2)

888 (81.5)

1797 (79.5)

315 (80.8)

0.016

  Malay

431 (11.5)

99 (9.1)

281 (12.4)

51 (13.1)

 

  Indian

215 (5.8)

72 (6.6)

122 (5.4)

21 (5.4)

 

  Others

93 (2.5)

30 (2.8)

60 (2.7)

3 (0.8)

 

 Highest qualification attained, n (%)

  No formal/primary

1358 (36.3)

241 (22.1)

837 (37.0)

280 (71.8)

<0.001

  Secondary

1651 (44.2)

545 (50.0)

1013 (44.8)

93 (23.8)

 

  Post-secondary (non-tertiary)

202 (5.4)

84 (7.7)

114 (5.0)

4 (1.0)

 

  Professional diploma

183 (4.9)

93 (8.5)

88 (3.9)

2 (0.5)

 

  Tertiary

227 (6.1)

94 (8.6)

131 (5.8)

2 (0.5)

 

  Missing

118 (3.2)

32 (2.9)

77 (3.4)

9 (2.3)

 

 Housing, n (%)

     

  HDB 1–3 rooms

912 (24.4)

192 (17.6)

566 (25.0)

154 (39.5)

<0.001

  HDB >3 rooms

2308 (61.7)

694 (63.7)

1408 (62.3)

206 (52.8)

 

  Private

462 (12.4)

193 (17.7)

247 (10.9)

22 (5.6)

 

  Other/missing

57 (1.5)

10 (0.9)

39 (1.7)

8 (2.1)

 

 Marital status, n (%)

     

  Married

2651 (70.9)

828 (76.0)

1595 (70.6)

228 (58.5)

<0.001

  Never married

469 (12.5)

126 (11.6)

299 (13.2)

44 (11.3)

 

  Widowed

421 (11.3)

84 (7.7)

244 (10.8)

93 (23.8)

 

  Separated or divorced

198 (5.3)

51 (4.7)

122 (5.4)

25 (6.4)

 

Lifestyle risk factors

 Smoking, n (%)

     

  No

3611 (96.6)

1063 (97.6)

2179 (96.4)

369 (94.6)

0.016

  Yes

128 (3.4)

26 (2.4)

81 (3.6)

21 (5.4)

 

 Alcohol, n (%)

     

  No

3633 (97.2)

1055 (96.9)

2194 (97.1)

384 (98.5)

0.251

  Yes

106 (2.8)

34 (3.1)

66 (2.9)

6 (1.5)

 

 Physical activity between ages 18 and 30 years, n (%)

  1

264 (7.1)

70 (6.4)

158 (7.0)

36 (9.2)

<0.001

  2

2517 (67.3)

673 (61.8)

1541 (68.2)

303 (77.7)

 

  3

210 (5.6)

78 (7.2)

126 (5.6)

6 (1.5)

 

  4

455 (12.2)

146 (13.4)

279 (12.3)

30 (7.7)

 

  5

293 (7.8)

122 (11.2)

156 (6.9)

15 (3.8)

 

Medical risk factors

 Charlson comorbidity index, n (%)

  0

2549 (68.2)

780 (71.6)

1552 (68.7)

217 (55.6)

<0.001

  1

852 (22.8)

216 (19.8)

520 (23.0)

116 (29.7)

 

  >1

334 (8.9)

93 (8.5)

184 (8.1)

57 (14.6)

 

  Missing

4 (0.1)

0 (0.0)

4 (0.2)

0 (0.0)

 

 Previous surgery for benign lump, n (%)

  No

3301 (88.3)

896 (82.3)

2038 (90.2)

367 (94.1)

<0.001

  Yes

435 (11.6)

193 (17.7)

221 (9.8)

21 (5.4)

 

  Missing

3 (0.1)

0 (0.0)

1 (0.0)

2 (0.5)

 

 Previous gynaecological surgery, n (%)

  No

2302 (61.6)

632 (58.0)

1414 (62.6)

256 (65.6)

0.007

  Yes

1431 (38.3)

456 (41.9)

844 (37.3)

131 (33.6)

 

  Missing

6 (0.2)

1 (0.1)

2 (0.1)

3 (0.8)

 

 Family history of breast cancer, n (%)

  No

2759 (73.8)

760 (69.8)

1687 (74.6)

312 (80.0)

<0.001

  Yes

837 (22.4)

294 (27.0)

482 (21.3)

61 (15.6)

 

  Missing

143 (3.8)

35 (3.2)

91 (4.0)

17 (4.4)

 

 Family history of ovarian cancer, n (%)

  No

3477 (93.0)

1017 (93.4)

2101 (93.0)

359 (92.1)

0.797

  Yes

107 (2.9)

32 (2.9)

62 (2.7)

13 (3.3)

 

  Missing

155 (4.1)

40 (3.7)

97 (4.3)

18 (4.6)

 

Reproductive risk factors

 Age at first full-term pregnancy, n (%)

  Nulliparous

725 (19.4)

200 (18.4)

462 (20.4)

63 (16.2)

<0.001

  <20

217 (5.8)

45 (4.1)

118 (5.2)

54 (13.8)

 

  20–24

808 (21.6)

209 (19.2)

497 (22.0)

102 (26.2)

 

  25–29

1113 (29.8)

349 (32.0)

661 (29.2)

103 (26.4)

 

  >30

853 (22.8)

283 (26.0)

510 (22.6)

60 (15.4)

 

  Missing

23 (0.6)

3 (0.3)

12 (0.5)

8 (2.1)

 

 Parity, n (%)

  0

725 (19.4)

200 (18.4)

462 (20.4)

63 (16.2)

<0.001

  1

459 (12.3)

126 (11.6)

295 (13.1)

38 (9.7)

 

  2

1296 (34.7)

442 (40.6)

762 (33.7)

92 (23.6)

 

  ≥3

1258 (33.6)

321 (29.5)

741 (32.8)

196 (50.3)

 

  Missing

1 (0.0)

0 (0.0)

0 (0.0)

1 (0.3)

 

 Infertility treatment, n (%)

  No

3590 (96.0)

1028 (94.4)

2178 (96.4)

384 (98.5)

<0.001

  Yes

149 (4.0)

61 (5.6)

82 (3.6)

6 (1.5)

 

 Oral contraception, n (%)

  No

2813 (75.2)

818 (75.1)

1698 (75.1)

297 (76.2)

0.906

  Yes

926 (24.8)

271 (24.9)

562 (24.9)

93 (23.8)

 

 Hormone replacement treatment, n (%)

  Never

3309 (88.5)

918 (84.3)

2018 (89.3)

373 (95.6)

<0.001

  Ever

401 (10.7)

161 (14.8)

227 (10.0)

13 (3.3)

 

  Missing

29 (0.8)

10 (0.9)

15 (0.7)

4 (1.0)

 

 Menopausal status at diagnosis, n (%)

  Post-menopausal

3084 (82.5)

845 (77.6)

1885 (83.4)

354 (90.8)

<0.001

  Pre-menopausal

655 (17.5)

244 (22.4)

375 (16.6)

36 (9.2)

 
  1. The p-value (P) for categorical variables is based on the chi-square test and the p-value for continuous variables is based on the Kruskal-Wallis test
  2. CGH Changi General Hospital, KKH KK Women’s and Children’s Hospital, NCC National Cancer Centre, NTFGH Ng Teng Fong General Hospital, NUH National University Hospital, SGH Singapore General Hospital, TTSH Tan Tock Seng Hospital, IQR interquartile range